08 October 2009

Differential diagnosis of the flu-like illness



The sepsis syndrome: Differential diagnosis of the flu-like illness
By:Divya Ahuja, M.D.

Med Micro 2008 Clinical Correlations #5
Traditional definitions

* Bacteremia (or fungemia): presence of microorganisms in the blood
* Sepsis: Harmful consequences of microbes or their toxins in blood or tissues
* Septicemia (or bloodstream infection): bacteremia with clinical manifestations
* Septic shock: shock due to sepsis, often with bloodstream infection

Revised definitions
* Systemic inflammatory response syndrome (SIRS)
* Sepsis
* Severe sepsis
* Septic shock

Systemic Inflammatory Response Syndrome (SIRS)
* Two or more of the following
o temperature > 38 degrees C (100.4 F)
o respirations > 20/minute
o Heart rate > 90 beats per minute
o leukocyte count > 12,000/cmm or < 4000/cmm or with > 10% band forms

Sepsis and Severe Sepsis
* Sepsis: SIRS plus a documented infection (culture proven or identified by visual inspection)
* Severe sepsis: Sepsis associated with organ dysfunction, abnormalities due to hypoperfusion (such as lactic acidosis, oliguria, or acute alteration in mental status), ARDS, DIC, low platelets

Septic shock
* Definition: Sepsis-induced hypotension despite fluid resuscitation and/or inotropic support, plus hypoperfusion abnormalities
* The hallmark of septic shock is low systemic vascular resistance, which distinguishes it from hemorrhagic shock and cardiogenic shock.

Multiple Organ Failure
* Some physiologic descriptors
o Serum creatinine
o Platelet count
o pO2/FiO2 ratio
o Serum bilirubin
o Glasgow coma score

Sepsis
* Sepsis has a 20-50% mortality
* Severity has increased recently
* Hospital case-fatality has declined
* Incidence is greatest in winter
* Risk factors for sepsis
o Bacteremia
o Advanced age
o Impaired immune system
o Community acquired pneumonia

Continuum of severity
* Incidence of positive blood cultures increases along the continuum
* Increased mortality rate
* Severe organ dysfunction manifested as
o Acute respiratory distress syndrome
o Acute renal failure
o Disseminated intravascular coagulation

Disseminated intravascular coagulopathy
Case #1
* 20-year-old college student in ER
* General malaise, low-grade fever, and rapid development of purplish discoloration on his face. (from when he left his house to the time he arrived at the emergency room).
* Blood cultures were drawn and he was admitted to the intensive care unit

Presentation
* Febrile, tachycardic, systolic BP-70
* Creatinine- 3.6, poor urine output
* Platelets-46000
* INR- 2.6
* Obtunded mental status
* Needing maximum ventilatory support
* Meningococcemia with Waterhouse-Friderichsen Syndrome and DIC
* Treat with penicillin, ceftriaxone or chloramphenicol.
* Family members and hospital employees in contact with respiratory secretions should receive prophylaxis. Attack rates for household contacts is 0.3-1%, 300-1000 times the rate in the general population (rifampin x 4 doses or cipro x 1 dose)

Epidemiology of meningococcal disease

Evaluation of blood cultures
* True-positive versus false-positive (contamination; pseudobacteremia)
* Transient versus intermittent versus continuous
* Polymicrobial versus unimicrobial
* Primary versus secondary

Clues to contamination
* Microorganisms that are usually not pathogenic, unless isolated from multiple cultures (e.g., coagulase-negative staphylococci; Bacillus species)
* < 2 positive cultures and/or delayed growth and/or < 1 cfu/ml
* Doesn’t “fit” the clinical picture

Patterns of bacteremia
* Transient: caused by manipulation of a flora-containing body surface
* Intermittent: typical of most infections giving rise to positive blood cultures
* Sustained (or continuous): characteristic of intravascular infections--endocarditis, endarteritis, suppurative thrombophlebitis, infected AV fistula

Number of microorganisms
* Unimicrobial (or “monomicrobial”) bacteremia: one isolate
* Polymicrobial bacteremia: more than one microorganism; typical of complicated situations often with surgical implications

Epidemiology of sepsis
* Contributes to > 100,000 deaths in the United States each year.
* Annual incidence is probably between 300,000 and 500,000 cases.
* About 2/3rds of cases occur in patients hospitalized for another illness (nosocomial infection).

Risk factors for nosocomial sepsis
* Gram-negative bacilli: diabetes mellitus; tumors; cirrhosis; burns; invasive procedures; neutropenia
* Gram-positive cocci: vascular access lines, devices
* Fungi: immunosuppression; broad-spectrum antibiotic therapy

Host factors in sepsis
* Mortality is directly related to severity of underlying disease: rapidly-fatal> ultimately fatal (i.e., within 5 years)>nonfatal.
* Elderly have increased mortality.
* Mortality is higher in patients with subnormal temperatures than in those with fever.

Clinical findings in sepsis
* Early: apprehension, hyperventilation, altered mental status
* Complications: hypotension, bleeding, leukopenia, thrombocytopenia, organ failure
* Lungs: cyanosis, acidosis, full-blown ARDS

Read more...

Emerging Infections and Medical Procedures



Emerging Infections and Medical Procedures

Parasitic Infections: Clinical Manifestations, Diagnosis and Treatment
By:Lennox K. Archibald, MD, PhD, FRCP, DTM&H
Hospital Epidemiologist
University of Florida

The Reality
* 1.3 billion persons infected with Ascaris (1: 4 persons on earth)
* 300 million with schistosomiasis
* 100 million new malaria cases/yr
* At UCLA, 38% of pediatric and dental clinic children harbored intestinal parasites

Case1
* 42-yr-old previously healthy, UF professor
* 6-week history of intermittent diarrhea, flatus and abdominal cramps
* Diarrhea: x8/day; pale; no blood or mucus
* No tenesmus
* Illness began slowly during camping trip to Colorado with loose stools
* Spontaneously remission for 5-6 days at a time, then recur
* His 8-yr-old son had had a mild course of watery diarrhea—ascribed to viral gastroenteritis by general practitioner
* Stool smear—no pus cells
* However, wet preps showed…

Diagnosis?
Giardiasis (G. lamblia)
* Should be suspected in prolonged diarrhea
* Contaminated water often implicated—outbreaks
* Campers who fail to sterilize mountain stream water
* Person-person in day care centers
* MSM
* Symptoms usually resolve spontaneously in 4-6 weeks

Giardiasis Tests of choice
* Examination of concentrated stools for cysts (90% yield after 3 samples)
o Usually no PMNs
* Stool ELISA, IF Antigen (up to 98% sensitive/90-100% specific)
* Consider aspiration of duodenal contents--trophozoites
* Treatment: Metronidazole for 5-7 days

Case 2
* 40 y/o male vicar returned from 2 years of missionary work in South Africa
* Excellent health throughout stay there
* 3 months after returning to U.S.
o Suddenly ill with abdominal distension
o Fever
o Periumbilical pain
o Vomiting
o Blood-tinged diarrheal stools
* Denied arthritis /known exposure to parasites
* Family history of “inflammatory bowel disease”
* Physical examination:
o Acutely ill
o Distended abdomen
o No hepatomegaly or splenomegaly
o Decreased bowel sounds
o Stool exam
+ Gross blood present
+ No pus cells
+ Negative for O&P, one negative C&S

Sigmoidoscopy revealed…
* Multiple punctate bleeding sites at 7 to 15 cm with normal appearing mucosa between sites
* This mucosa easily denuded when pressure applied to it, leaving large areas of bleeding submucosa
* Diagnosed with ulcerative colitis
* Started on corticosteroids
* Temperature rose to 40°C
* Abdomen distension increased and worsening of symptoms
* Emergency laparotomy for toxic megacolon

Diagnosis?
Entamoeba histolytica
* One of 7 amoebae commonly found in humans
* Only one that causes significant disease
* Causes intestinal (diarrhea and dysentery) and extraintestinal (liver primarily) disease
* In US
o Institutionalized patients
o MSM
o Tourists returning from developing countries
o Patients with depressed cell mediated immunity

Trophozoites with ingested RBC
Trophozoites in colon tissue (H & E stain)
Cyst (wet mount)

Amoebiasis: Clinical Manifestations
* Symptoms depend on degree of bowel invasion
o Superficial: watery diarrhea and nonspecific GI complaints
o Invasive: gradual onset (1-3 weeks) of abdominal pain, bloody diarrhea, tenesmus
* Fever is seen in minority of patients
* Can be mistaken for ulcerative colitis
* Steroids can dramatically worsen and precipitate toxic megacolon
* Amebic liver abscesses
o RUQ pain, pain referred to right shoulder
o High fever
o Hepatomegaly (50%)

Amoebic abscess—remember…
* Can occur in lung, brain, spleen
Amoebic Abscess
* Liquefaction of liver cells
* Do not contain pus
* Anchovy paste sauce
* Culture of contents usually sterile
* Liver affected:
o 53%-right lobe
o 8%-left lobe

Remember…
* That stool is merely a convenient vehicle passing by
* Amoebae live the bowel wall
* Direct observation preferable to mere examination of stool
* Trophozoites best seen in direct scrapings of ulcers

Amoebiasis Treatment
* Most respond to metronidazole
* Open surgical drainage should be avoided, if at all possible

Case 3
* Previously healthy 3-year-old girl
* Attends day-care center
* 7 day history of watery diarrhea
* Nausea
* Vomiting
* Abdominal cramps
* Low-grade fever

Case 4
* 34 year-old AIDS patient
* Debilitating, cholera-like diarrhea
* Severe abdominal cramps
* Malaise
* Low-grade fever
* Weight loss
* Anorexia

Diagnosis? Case 3 & 4

Three cysts stained pale red are seen in the center with this acid fast stain
Modified acid-fast stain of stool showing red oocysts of Cryptosporidium parvum against the blue background of coliforms and debris

Cryptosporidium parvum
* Causes secretory diarrhea: 10 liter/day
* Significant cause of death in HIV/AIDS
* Animal reservoirs
* Incubation period: 5-10 days

Cryptosporidium parvum
* Infants & young children in day-care
* Unfiltered or untreated drinking water
* Farming practices: lambing, calving, and muck-spreading
* Sexual practices: oral contact with stool of an infected individual
* Nosocomial setting with other infected patients or health-care employees
* Veterinarians: contact with farm animals
* Travelers to areas with untreated water
* Living in densely populated urban areas
* Owners of infected household pets (rare)

Diagnosis and Treatment
* Best diagnosed by stool exam
* No known effective treatment
* Nitazoxamide shortens duration of diarrhea

Case 5
* Mr. & Mrs. R. were sailing with their 3 children in Jamaica
* Living primarily on the boat with several day trips to a small coastal island
* On island, ate several types of tropical fruit
* Both became suddenly ill with fevers, chills, muscle aches, and loss of appetite.
* Sought treatment locally, and were diagnosed with hepatitis, likely due to ingestion of toxic fruit

Case 5
* Two days later, Mr. R. became jaundiced and passed dark urine
* He progressively worsened, became comatose and died
* In the meantime, Mrs. R. was transferred to SUF for liver transplant
* None of the children were sick despite having eaten the same fruits and other foods.
* The family had taken chloroquine prophylaxis against malaria, but the parents stopped the medicine 2 weeks prior to becoming ill because of side effects.

Falciparum vs. Vivax
* Location: Falciparum confined to tropics and subtropics; vivax more temperate
* Falciparum infects RBC of any age; others like reticulocytes
* Falciparum-infected RBCs stick to vascular endothelium causing capillary blockage

Malaria: Genetic susceptibility
* Two genetic traits associated with decreased susceptibility to malaria
* Absence of Duffy blood group antigen blocks invasion of Plasmodium vivax
o Significant number of Africans
* Persons with sickle cell hemoglobin are resistant to P. falciparum
* Sickle cell disease and trait

Malaria: Clinical manifestations
* Non-specific, flu-like illness
* Incubation
o P. falciparum: 9-40 days
o Non-P. falciparum: may be prolonged
+ P. vivax: 6-12 months
+ P. malariae and ovale: years
* Fever is the hallmark of malaria
o Classically, 2-3 day intervals in P. vivax and malariae
o More irregular pattern in P. falciparum
* Fever occurs after the lysis of RBCs and release of merozoites

Malaria: Clinical manifestations
* Febrile paroxysms have 3 classic stages
o Cold stage
+ Pt feels cold and has shaking chills
+ 15-60 mins. prior to fever
o Hot stage
+ 39-41°C
+ Lassitude, loss of appetite, bone and joint aches
+ Tachycardia, hypotension, cough, HA, back pain, N/V, diarrhea, abdo pain, altered consciousness
o Sweating stage
+ Marked diaphoresis followed by resolution of fever, profound fatigue, and sleepiness
+ 2-6 hours after onset of hot stage
* Other symptoms depend on malaria strain
* P. vivax, ovale and malariae: few other sxs
* P. falciparum:
o Dependent upon host immune status
o No prior immunity/splenectomy  high levels of parasitemia  profound hemolysis
o Vascular obstruction and hypoxia
+ Kidneys: renal failure
+ Brain: (CNS) ― hypoxia, coma, seizures
+ Lungs: pulmonary edema
o Jaundice & hemoglobinuria (blackwater fever)
* Always suspect malaria in travelers from developing countries who present with:
o Influenza-like illness
o Jaundice
o Confusion or obtundation

Diagnosis
* Giemsa-stained blood smear
o Thick and thin smears
* P. falciparum:
o Best just after fever peak
* Others:
o Smears can be performed at any time
* Examine blood on 3-4 successive days

Differences in strains
* P. falciparum
o No dormant phase in liver
o Multiple signet ring trophs per cell
o High percentage (>5%) parasitized RBCs considered severe

Differences in strains
* P. vivax and ovale
o Dormant liver phase
o Single signet ring trophs per cell
o Schuffner’s dots in cytoplasm
o Low percent (< 5%) of parasitized RBCs
* P. malariae
o No dormant stage
o Single signet ring trophs per cell
o Very low parasitemia

Treatment
* P. falciparum malaria can be fatal if not promptly diagnosed and treated
* Non- P. falciparum malaria rarely requires hospitalization

Treatment
Uncomplicated malaria
* P. vivax, ovale, malariae, chloroquine-susceptible falciparum
o Chloroquine
o Primaquine for dormant liver forms
* Chloroquine-resistant falciparum
o Quinine plus doxycycline
o Mefloquine
o Atovaquone plus proguanil (AP)
o Artemisins (common in SE Asia due to multi-drug resistance)

Treatment Severe malaria
* Drug options
o Quinidine gluconate—only approved parenteral agent in US
o Artemisin
Prevention
* Mefloquine
* Doxycycline
* Nets
* 30-35% DEET
* Permethrin spray for clothing and nets

And don’t forget baggage malaria!
Case 5
* Mrs. R. was treated with IV quinidine and improved rapidly.
* In retrospect, Mr. R. had died from untreated blackwater fever
o Few parasites in peripheral blood
o Acute renal failure

Case 6
* A 24-year-old white male army officer
* Referred to the VA ID clinic with a 3-month history of a lesion on his right leg, developing approximately 2 weeks after returning from Iraq
* Recent travel history: 1 month in Kuwait and 2 months traveling between Kuwait and Iraq
* Recalled being bitten numerous times by small flying insects and other nasty “bugs”

Physical examination essentially normal except for:
* Non-tender (20 × 15 mm) scaly erythematous plaque with a moist central erosion of the left popliteal area.
* There was no lymphadenopathy and no mucosal lesions were noted

Diagnosis?
An intact macrophage practically filled with amastigotes (arrows),

Leishmaniasis
* Tropical areas where phlebotomine sandfly is common: South America, India, Bangladesh, Middle East, East Africa
* Sandfly introduces flagellated promastigote into human  ingested by macrophages  develops into nonflagellated amastigote
* Cutaneous
o Most common among farmers, settlers, troops and tourists in Mid East (L. major and tropica), Central and South America (L. mexicana, braziliensis, amazonensis, and panamensis)
o L. mexicana reported in Texas
* Visceral (kala azar)
o Anemia, leukopenia, thrombocytopenia, hypergammaglobulinemia common

Leishmaniasis: Diagnosis
* Biopsy and Giemsa stain with amastigotes
* Species most prevalent in different places
# L. donovani – India
# L. infantum – Mid East
# L. chagasi – Latin America
# L. amazonensis -- Brazil

Visceral Leishmaniasis
* Dissemination of amastigotes throughout the reticulendothelial system of the body
o Spleen
o Bone marrow
o Lymph nodes
* Opportunistic infection in AIDS patients
* Ineffective humeral response

Hepatosplenomegaly
Splenic aspirate
* Most satisfactory method
* Spleen must be at least 3cm below LCM
* Aspirate stained with Giemsa

Leishmaniasis: treatment
* Only drug approved in US is Amphotericin B
* Treatment of cutaneous disease depends on anatomic location
* Many spontaneously heal and do not require treatment

Remember..
* The factors determining the form of leishmaniasis:
o Leishmanial species
o Geographic location
o Immune response of the host

Case 7
* 38-year-old businessman
* Previously fit
* 2-week history of fever since returning from Brazil business trip
* Flu-like symptoms and myalgia
* Had consumed steak tartare in Brazil
* Results all unremarkable---normal WBC and ESR; negative smears; CXR and urine OK
* Continued to have fever, tachycardia and myalgia

Case 8
* A 29-yr-old man with AIDS (CD4 count=59) presents with a 2 week history of headache, fevers and new onset seizures
* He had not been taking any antiretroviral medications

Cases 7 & 8
What parasite could
cause this picture?
AIDS Patient
Toxoplasma gondii cyst in brain tissue with H & E stain (100x)
For the businessman…
* Toxoplasma serology was positive at a very high titer
* Responded to treatment with sulphonamide + pyrimethamine
* No relapse

Transmission
* Eating oocysts excreted by cats harboring sexual stages of parasite
* Outbreaks traced to inadequately cooked meat of herbivores (raw beef)
* Mutton

Toxoplasma gondii
* Worldwide distribution
* Human infection
o Ingestion of cysts in undercooked meat of herbivores
o Water/food contaminated with oocysts
o Congenitally
o Infected organs, blood (less common)
* Prevalence of latent infection in US about 10%; France about 75%
o Generally higher in less-developed world
o 50% in AIDS patients; up to 90% of AIDS patients in developing world

Toxoplasma gondii: Immunocompetent hosts
* Latent infection (persistence of cysts) is generally asymptomatic
* Cervical lymphadenopathy (10-20%)
* Mono-like presentation (<1% of all mono-like illnesses)
* Chorioretinitis
* Very rare: myocarditis, myositis

Toxoplasma gondii: Immunocompromised hosts

Read more...

Differentiating Babesia from Malaria



Differentiating Babesia from Malaria
By:Devak Desai

Case Presentation
* Middle aged hypertensive and asplenic man presented with a pruritic rash on his right buttock accompanied by flu-like symptoms.
* 1010, arthralgias, myalgias, some nausea, and general malaise, and decreased appetite.
* Reports walking through a wooded area on Martha’s Vineyard, an island off the coast of Mass.
* PE shows a well nourished man with no significant findings other than an erythmatous oropharynx without exudate.

Laboratory Data
* Normal WBC differential
* Blood smear: numerous intraerythrocytes involving 2.7% of RBCs
* Direct Combs test was negative
* Positive serologic test for Lyme Disease

Peripheral Blood Smear
* Numerous erythrocytes are infected with the predominantly ring or pear-shaped form of Babesia microti.
* Pleomorphic rings with 1-3 chromotin dots per parasite.
* 3 dots is unique for Babesia.

Host Infection Cycle
* Infection begins when sporozoites are released from the deer tick’s salivary gland during a blood meal.
* Sporozoites replicate directly in RBCs.
* Attachment and adsorption seems mediated through the C3b receptor.
* During invagination a clear vacuole appears.
* Babesia divided by asynchronous budding.
* The replicating structures are now called trophozoites.
* This is an asynchronous process with varying degrees of hemolysis.

Life cycle of Babesia spp. in the tick and vertebrate hosts
High Power
* Ring shaped trophozites
* The intraerythrocytic trophozoites multiply by binary fission or schizogony, forming two to four separate merozoites.
* White eccentric “food vacuole” in a ring form.
* Very transient stage in Malaria. Very rarely seen.

the famous Maltese Cross
* Presence of 4 daughter merozoites in a tetrad is pathomnemonic.
* However, rarely seen.
* Never seen in malaria.

Multiply infected RBCs
* RBCs can be infected with multiple organisms at the same time. Up to 12 parasites may infect a single RBC.
* Plasmodium has up to 3 parasites/RBC.
* Unremarkable RBCs.

Other Sightings
* Parasite with a peripheral nuclear band
* Basket cell
* Syncytium of extracellular parasites
* Far more common in Babesia infections

Malaria Review

Read more...

06 October 2009

Hyponatremia



Hyponatremia
By :
James Yost, MD, MS, MBA
Emory Family Medicine

Hyponatremia
* Definition
* Epidemiology
* Physiology
* Pathophysiology
* Types
* Clinical Manifestations
* Diagnosis
* Treatment

Hyponatremia
* Definition:
o Commonly defined as a serum sodium concentration 135 meq/L
o Hyponatremia represents a relative excess of water in relation to sodium.
* Epidemiology:
o Frequency
+ Hyponatremia is the most common electrolyte disorder
+ incidence of approximately 1%
+ prevalence of approximately 2.5%
+ surgical ward, approximately 4.4%
+ 30% of patients treated in the intensive care unit
o Mortality/Morbidity
+ Acute hyponatremia (developing over 48 h or less) are subject to more severe degrees of cerebral edema
# sodium level is less than 105 mEq/L, the mortality is over 50%
+ Chronic hyponatremia (developing over more than 48 h) experience milder degrees of cerebral edema
# Brainstem herniation has not been observed in patients with chronic hyponatremia
o Age
+ Infants
# fed tap water in an effort to treat symptoms of gastroenteritis
# Infants fed dilute formula in attempt to ration
+ Elderly patients with diminished sense of thirst, especially when physical infirmity limits independent access to food and drink
* Physiology
o Serum sodium concentration regulation:
+ stimulation of thirst
+ secretion of ADH
+ feedback mechanisms of the renin-angiotensin-aldosterone system
+ renal handling of filtered sodium
o Stimulation of thirst
+ Osmolality increases
# Main driving force
# Only requires an increase of 2% - 3%
+ Blood volume or pressure is reduced
# Requires a decrease of 10% - 15%
+ Thirst center is located in the anteriolateral center of the hypothalamus
# Respond to NaCL and angiotensin II
o Secretion of ADH
+ Synthesized by the neuroendocrine cells in the supraoptic and paraventricular nuclei of the hypothalamus
+ Triggeres:
# Osmolality of body fluids
* A change of about 1%
# Volume and pressure of the vascular system
+ Increases the permeability of the collecting duct to water and urea
o renin-angiotensin-aldosterone
+ Renin
# Stemuli are perfusion pressure, sympathetic activity, and NaCl delivery to the macula densa
# Increase in NaCl delivery to the macula decreases the GFR by decrease in the renin secretion
+ Aldosterone
# Reduces NaCl excretion by stimulating it’s resorption
* Ascending loop of Henle
* Distal tubule
* Collecting duct
o extracellular-fluid and intracellular-fluid compartments make up 40 percent and 60 percent of total body water
o renal handling of water is sufficient to excrete as much as 15-20 L of free water per day
o sodium is the predominant osmole in the extracellular fluid (ECF) compartment and serum

* Pathophysiology
o hyponatremia can only occur when some condition impairs normal free water excretion
o acute drop in the serum osmolality:
+ neuronal cell swelling occurs due to the water shift from the extracellular space to the intracellular space
+ Swelling of the brain cells elicits 2 responses for osmoregulation, as follows:
# It inhibits ADH secretion and hypothalamic thirst center
# immediate cellular adaptation
* Types
o Hypovolemic hyponatremia
o Euvolemic hyponatremia
o Hypervolemic hyponatremia
o Redistributive hyponatremia
o Pseudohyponatremia
Hypovolemic hyponatremia
* develops as sodium and free water are lost and/or replaced by inappropriately hypotonic fluids
* Sodium can be lost through renal or non-renal routes
* Nonrenal loss
o GI losses
+ Vomiting, Diarrhea, fistulas, pancreatitis
o Excessive sweating
o Third spacing of fluids
+ ascites, peritonitis, pancreatitis, and burns
o Cerebral salt-wasting syndrome
+ traumatic brain injury, aneurysmal subarachnoid hemorrhage, and intracranial surgery
+ Must distinguish from SIADH
* Renal Loss
o Acute or chronic renal insufficiency
o Diuretics

Euvolemic hyponatremia
* Normal sodium stores and a total body excess of free water
o Psychogenic polydipsia, often in psychiatric patients
o Administration of hypotonic intravenous or irrigation fluids in the immediate postoperative period
o administration of hypotonic maintenance intravenous fluids
o Infants who may have been given inappropriate amounts of free water
o bowel preparation before colonoscopy or colorectal surgery
* SIADH
o downward resetting of the osmostat
o Pulmonary Disease
+ Small cell, pneumonia, TB, sarcoidosis
o Cerebral Diseases
+ CVA, Temporal arteritis, meningitis, encephalitis
o Medications
+ SSRI, Antipsychotics, Opiates, Depakote, Tegratol

* Total body sodium increases, and TBW increases to a greater extent.
* Can be renal or non-renal
o acute or chronic renal failure
+ dysfunctional kidneys are unable to excrete the ingested sodium load
o cirrhosis, congestive heart failure, or nephrotic syndrome

Redistributive hyponatremia
o Water shifts from the intracellular to the extracellular compartment, with a resultant dilution of sodium. The TBW and total body sodium are unchanged.
+ This condition occurs with hyperglycemia
+ Administration of mannitol
* Pseudohyponatremia
o The aqueous phase is diluted by excessive proteins or lipids. The TBW and total body sodium are unchanged.
+ hypertriglyceridemia
+ multiple myeloma
* Clinical Manifestations
o most patients with a serum sodium concentration exceeding 125 mEq/L are asymptomatic
o Patients with acutely developing hyponatremia are typically symptomatic at a level of approximately 120 mEq/L
o Most abnormal findings on physical examination are characteristically neurologic in origin
o patients may exhibit signs of hypovolemia or hypervolemia
* Diagnosis
o CT head, EKG, CXR if symptomatic
o Repeat Na level
o Correct for hyperglycemia
o Laboratory tests provide important initial information in the differential diagnosis of hyponatremia
+ Plasma osmolality
+ Urine osmolality
+ Urine sodium concentration
+ Uric acid level
+ FeNa
o Plasma osmolality

Read more...

Fluid, Electrolyte & Acid-Base Balance



Fluid, Electrolyte & Acid-Base Balance

Body Fluids
* Your body is 66% water
* Not evenly distributed – separated into compartments
* Able to move back and forth thru the cell membranes to maintain an equilibrium

Fluid Compartments
* Intracellular fluid – fluid inside cells [ICF]
* Extracellular fluid – fluid outside cells and all other body fluids --- ž is plasma [intravascular fluid], remaining ū is interstitial fluid. Small amount is localized as CSF, serous fluid, synovial fluid, humors of eye & endo/perilymph of ears

Edema
* Condition in which fluid accumulates in the interstitial compartment. Sometimes due to blockage of lymphatic vessels or by a lack of plasma proteins or sodium retention

Fluid Balance
* Amount in = amount out
* Average daily intake is 2500 ml [ fluids, food and metabolic water]
* Average daily output is 2500 ml [ urine, feces, perspiration, insensible perspiration]
* What can throw off these numbers?

Electrolyte Balance
* Def: - concentration of individual electrolytes in the body fluid compartments is normal and remains relatively constant.
* Electrolytes are dissolved in body fluids
* Sodium predominant extracellular cation, and chloride is predominant extracellular anion. Bicarbonate also in extracellular spaces
* Potassium is the predominant intracellular cation and phosphates are the predominant intracellular anion
* Cations are actively reabsorbed, anions passively follow by electrochemical attraction
* Aldosterone works at kidney tubules to regulate sodium & potassium levels
* Because of sodium and potassium influence, water will move between compartments
* Example: if high [sodium], then water will move from intracellular space to extracellular space due to osmotic pressure

Balance of other Electrolytes

Read more...

Evaluation of Laboratory Data in Nutrition Assessment



Evaluation of Laboratory Data in Nutrition Assessment
By:Cinda S. Chima, MS, RD

Laboratory Data and the NCP
* Used in nutrition assessment (a clinical sign supporting nutrition diagnosis)
* Used in Monitoring and Evaluation of the patient response to nutritional intervention

Specimen Types
* Serum: the fluid from blood after blood cells and clot removed
* Plasma: fluid from blood centrifuged with anticoagulants
* Erythrocytes: red blood cells
* Leukocytes: white blood cells
* Other tissues: scrapings and biopsy samples
* Urine: random samples or timed collections
* Feces: random samples or timed collections
* Less common: saliva, nails, hair, sweat

Interpretation of Routine Medical Laboratory Tests
* Clinical Chemistry Panels
o Basic metabolic panel
o Comprehensive metabolic panel
* Complete blood count
* Urinalysis
* Hydration status

Clinical Chemistry Panels: Basic Metabolic Panel (BMP)
Also called Chem 7
Includes
o Electrolytes: Na+, K+, Cl-, HCO3 or total CO2
o Glucose
o Creatinine
o BUN
Basic Metabolic Panel Charting Shorthand
Creatinine
CO2
K+
glucose
BUN
Cl
Na
BMP
Clinical Chemistry Panels: Comprehensive Metabolic Panel
Includes
* BMP except CO2
* Albumin
* Serum enzymes (alkaline phosphatase, AST [SGOT], ALT [SGPT]
* Total bilirubin
* Total calcium
Phosphorus, total cholesterol and triglycerides often ordered with the CMP

Clinical Chemistry Panels:
Complete Blood Count (CBC)
* Red blood cells
* Hemoglobin concentration
* Hematocrit
* Mean cell volume (MCV)
* Mean cell hemoglobin (MCH)
* Mean cell hemoglobin concentration (MCHC)
* White blood cell count (WBC)
* Differential: indicates percentages of different kinds of WBC

Clinical Chemistry Panels: Urinalysis
Negative
Leukocyte esterage
Negative
Nitrite
0.1-1 units/dl
Urobilinogen
Not detected
Bilirubin
Negative
Blood
Negative
Ketones
Not detected
Glucose
2-8 mg/dl
Protein
6-8 (normal diet)
pH
1.010-1.025 mg/ml
Specific gravity
Types of Assays
* Static assays: measures the actual level of the nutrient in the specimen (serum iron, white blood cell ascorbic acid)
* Functional Assays: measure a biochemical or physiological activity that depends on the nutrient of interest (serum ferritin, TIBC)
o (Functional assays are not always specific to the nutrient)

Assessment of Nutrient Pool
Assessment of Hydration Status
* Dehydration: a state of negative fluid balance caused by decreased intake, increased losses, or fluid shifts
* Overhydration or edema: increase in extracellular fluid volume; fluid shifts from extracellular compartment to interstitial tissues
o Caused by increase in capillary hydrostatic pressure or permeability
o Decrease in colloid osmotic pressure
o Physical inactivity
* Use laboratory and clinical data to evaluate pt

Hypovolemia
Isotonic fluid loss from the extracellular space caused by
* Fluid loss (bleeding, fistulas, nasogastric drainage, excessive diuresis, vomiting and diarrhea)
* Reduced fluid intake
* Third space fluid shift, when fluid moves out of the intravascular space but not into intracellular space (abdominal cavity, pleural cavity, pericardial sac) caused by increased permeability of the capillary membrane or decrease on plasma colloid osmotic pressure

Symptoms of Hypovolemia
* Orthostatic Hypotension (caused by change in position)
* Central venous and pulmonary pressures 
* Increased heart rate
* Rapid weight loss
* Decreased urinary output
* Patient cool, clammy
* Decreased cardiac output
* Ask the medical team!!
Treatment of Hypovolemia
* Replace lost fluids with fluids of similar concentration
* Restores blood volume and blood pressure
* Usually isotonic fluid like normal saline or lactated Ringer’s solution given IV
* Excess of isotonic fluid (water and sodium) in the extracellular compartment
* Osmolality is usually not affected since fluid and solutes are gained in equal proportion
* Elderly and those with renal and cardiac failure are at risk

Causes of Hypervolemia
* Results from retention or excessive intake of fluid or sodium or shift in fluid from interstitial space into the intravascular space
* Fluid retention: renal failure, CHF, cirrhosis of the liver, corticosteroid therapy, hyperaldosteronism
* Excessive intake: IV replacement tx using normal saline or Lactated Ringer’s, blood or plasma replacement, excessive salt intake
* Fluid shifts into vasculature caused by remobilization of fluids after burn tx, administration of hypertonic fluids, use of colloid oncotic fluids such as albumin

Symptoms of Hypervolemia
* No single diagnostic test, so signs and symptoms are key
* Cardiac output increases
* Pulse rapid and bounding
* BP, CVP, PAP and pulmonary artery wedge pressure rise
* As the heart fails, BP and cardiac output drop
* Distended veins in hands and neck
* Anasarca: severe, generalized edema
* Pitting edema: leaves depression in skin when touched
* Pulmonary edema: crackles on auscultation
* Patient SOB and tachypneic
* Labs: low hematocrit, normal serum sodium, lower K+ and BUN (or if high, may mean renal failure)
* ABG: low O2 level, PaCO2 may be low, causing drop in pH and respiratory alkalosis

Treatment of Hypervolemia
* Restriction of sodium and fluid intake
* Diuretics to promote fluid loss; morphine and nitroglycerine to relieve air hunger and dilate blood vessels; digoxin to strengthen heart
* Hemodialysis or CAVH

Dehydration
* Excessive loss of free water
* Loss of fluids causes an increase in the concentration of solutes in the blood (increased osmolality)
* Water shifts out of the cells into the blood
* Causes: prolonged fever, watery diarrhea, failure to respond to thirst, highly concentrated feedings, including TF

Symptoms of Dehydration
* Thirst
* Fever
* Dry skin and mucus membranes, poor skin turgor, sunken eyeballs
* Decreased urine output
* Increased heart rate with falling blood pressure
* Elevated serum osmolality; elevated serum sodium; high urine specific gravity
* Use hypotonic IV solutions such as D5W
* Offer oral fluids
* Rehydrate gradually

Laboratory Values and Hydration: BUN
Low: inadequate dietary protein, severe liver failure
High: prerenal failure; excessive protein intake, GI bleeding, catabolic state; glucocorticoid therapy
Creatinine will also rise in severe hypovolemia
Decreases
Increases
BUN
Normal: 10-20 mg/dl
Other factors influencing result
Hyper-volemia
Hypo-volemia
Lab Test
Adapted from Charney and Malone. ADA Pocket Guide to Nutrition Assessment, 2004.
Laboratory Values and Hydration Status: BUN:Creatinine Ratio
Low: inadequate dietary protein, severe liver failure
High: prerenal failure; excessive protein intake, GI bleeding, catabolic state; glucocorticoid therapy
Decreases
Increases
BUN: creatinine ratio
Normal: 10-15:1
Other factors influencing result
Hyper-volemia

Read more...

HIV/AIDS 2008 Update



HIV/AIDS 2008 Update
By:David H. Spach, MD
Clinical Director, NWAETC
Professor of Medicine
Division of Infectious Diseases
University of Washington, Seattle

* HIV Epidemiology
* HIV Rapid Testing
* 2008 DHHS ARV Therapy Guidelines
* Antiretroviral Therapy: New Information in 2008
* New Scientific Discoveries
DHS/PP
Epidemiology*
Question
* In August 2008, the CDC reported their use of new epidemiologic methods that has led to significant revisions in the estimates of HIV incidence in the United States.

DHS/PP
In this recent report, which one of the following statements is TRUE regarding HIV infections in the United States in 2006?

* The number of estimated new infections in 2006 has been revised to a lower number (now 32,000 instead of 40,000)
* The rate (per 100,000 persons) of new infections in blacks was 7x whites
* Heterosexual sex has replaced male-to-male sex as the leading transmission category for new infections
* The number of new infections in women was greater than men
* “Based on extrapolations from these data, the estimated number of new infections for the United States in 2006 was 56,300.”
* “... the level of new HIV infections in the United States is higher than had previously been known, in fact approximately 40% higher than early estimates…”
Kevin Fenton, MD, PhD
Centers for Disease Control & Prevention.
HIV Rapid Testing*
Rapid HIV Tests
* In the June 18, 2008 issue of the MMWR, the NY City Department of Health and the CDC reported a problem with the OraQuick ADVANCE Rapid HIV-1/2 Antibody Test.

What was the reported problem with the OraQuick rapid HIV test?
* Contamination of test kits with mold
* Kits were shipped too close to the expiration date
* Failure of external Kit Controls to validate the assay
* Increased numbers of False-Positive results with oral fluid samples

Persons NOT Infected with HIV
OraQuick Rapid ORAL HIV Test
Confirmatory HIV Test (EIA/WB)
Preliminary
Positive
EIA
WB
Reactive
Oral Fluid
Oral
Possible Revised Approach: Rapid HIV Testing
OraQuick Rapid HIV Tests
Confirmatory HIV Test (EIA & WB)
Preliminary
Positive
Reactive
Oral
Oral Fluid
EXAMPLE: Specificity of HIV Antibody Test
Persons NOT Infected with HIV (N = 15)
EXAMPLE: Specificity of HIV Antibody Test
Antibody Test Result: Persons NOT Infected with HIV
EXAMPLE: Specificity of HIV Antibody Test
HIV Antibody Testing in Low Prevalence Setting
HIV Test Specificity
HIV Antibody Testing in Low Prevalence Setting
DHHS ARV Guidelines
Initiating Antiretroviral Therapy
* As a group, make a list of at least 5 recommendations regarding initiating antiretroviral therapy that are new/different in current 2008 guidelines when compared with guidelines that existed one year ago at this time (at that time October 2006 most recent updated version).
Initiating Antiretroviral Therapy
* NEW RECOMMENDATIONS
1. New CD4 threshold (350 cells/mm3 in 2008 instead of 200)
2. New indications for starting ARV (chronic HBV, HIVAN) in 2008
3. Less impact of HIV RNA level in 2008
4. Zidovudine-lamivudine removed from preferred list in 2008
5. Abacavir-lamivudine added to preferred list in 2008
6. Do HLA-B5701 testing if considering using abacavir
Initiating Antiretroviral Therapy January 2008 DHHS Guidelines
*Initiate Antiretroviral Therapy
Consider Antiretroviral Therapy
Construct Regimen by choosing one component from Column A and one component from Column B
Recent Concerns Regarding Abacavir
Antiretroviral Therapy New Information in 2008
Host Cellular Receptors
Extracellular Space
Intracellular Space
Entry Inhibitor: Maraviroc (Selzentry)

Read more...
All links posted here are collected from various websites. No video or powerpoint files are uploaded on this blog. If you are the original author and do not wish to display your content on this blog please Email me anandkumarreddy at gmail dot com I will remove it. The contents of this blog are meant for educational purpose and not for commercial use. If you use any content give due credit to the original author.

This site uses cookies from Google to deliver its services, to personalise ads and to analyse traffic. Information about your use of this site is shared with Google. By using this site, you agree to its use of cookies.

  © Blogger templates Newspaper III by Ourblogtemplates.com 2008

Back to TOP